Back to
Hood River Capital Management LLC
BBIO4 quarters
Position history for
Hood River Capital Management LLC's holdings in BRIDGEBIO PHARMA INC
Yes. Hood River Capital Management holds 1,347,535 shares of BBIO (Bridgebio Pharma), worth $100.4M, as of its Q2 2026 13F filing. It increased the position by 82,455 shares (+6.5%) from Q1 2026. Hood River Capital Management has held BBIO since Q3 2025, across 4 quarterly 13F filings. BBIO is 0.7% of Hood River Capital Management's reported 13F portfolio.
Current Value
$100.4M
Current Shares
1.3M
Total Value Change
+$35.8M
Total Shares Change
+103,990
Quarter-by-Quarter History
Other major holders of BBIO: VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC